Walmart plans to cover more than 250 prescriptions, including some insulin, inhalers and GLP-1s for diabetes, at no cost to employees in 2027. The company is expanding existing benefits and adding new ones to attract and retain workers, while many other employers are offsetting rising healthcare costs with higher prices and scaled-back benefits. Ozempic and Mounjaro will be free for Type 2 diabetes patients after a new prior authorization, but Walmart still does not cover Novo's and Lilly's GLP-1s for weight loss. The starting plan's premium rises $1.50 per pay period to $39.80, a smaller increase than last year. Starting next year, employees can get second opinions from specialists at the Mayo Clinic or Cleveland Clinic for rare conditions such as ALS, multiple sclerosis and Parkinson's, and parents get 12 weeks of neonatal intensive care unit leave on top of regular parental and maternity leave. Open enrollment closes on Nov. 6.
Summary written by Upside AI from the original article. Read the source for full details.
Get briefings and signals on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the morning, midday and evening briefing of each market and important news as it happens.